Mapping convergent regulators of melanoma drug resistance by PerturbFate
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 320 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- MelanomaThis series is part of our curated briefing on it.
- Samples
- 320 samples: 128 × PerturbFate pooled screen Tri-omics New RNA vs 128 × PerturbFate pooled screen Tri-omics Old RNA and ATAC vs 64 × PerturbFate pooled screen Dual-omicsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Mapping convergent regulators of melanoma drug resistance by PerturbFateNature · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE291147_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1231621 and SRA study SRP567948. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 320 samples.
How we read this: 3 replicated groups read from 320 sample titles; they account for 320 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8829735 PerturbFate pooled screen Dual-omics-01 PerturbFate pooled scre…
- GSM8829736 PerturbFate pooled screen Dual-omics-02 PerturbFate pooled scre…
- GSM8829737 PerturbFate pooled screen Dual-omics-03 PerturbFate pooled scre…
- GSM8829738 PerturbFate pooled screen Dual-omics-04 PerturbFate pooled scre…
- GSM8829739 PerturbFate pooled screen Dual-omics-05 PerturbFate pooled scre…
- GSM8829740 PerturbFate pooled screen Dual-omics-06 PerturbFate pooled scre…
- GSM8829741 PerturbFate pooled screen Dual-omics-07 PerturbFate pooled scre…
- GSM8829742 PerturbFate pooled screen Dual-omics-08 PerturbFate pooled scre…
- GSM8829743 PerturbFate pooled screen Dual-omics-09 PerturbFate pooled scre…
- GSM8829744 PerturbFate pooled screen Dual-omics-10 PerturbFate pooled scre…
- GSM8829745 PerturbFate pooled screen Dual-omics-11 PerturbFate pooled scre…
- GSM8829746 PerturbFate pooled screen Dual-omics-12 PerturbFate pooled scre…
- GSM8829747 PerturbFate pooled screen Dual-omics-13 PerturbFate pooled scre…
- GSM8829748 PerturbFate pooled screen Dual-omics-14 PerturbFate pooled scre…
- GSM8829749 PerturbFate pooled screen Dual-omics-15 PerturbFate pooled scre…
- GSM8829750 PerturbFate pooled screen Dual-omics-16 PerturbFate pooled scre…
- GSM8829751 PerturbFate pooled screen Dual-omics-17 PerturbFate pooled scre…
- GSM8829752 PerturbFate pooled screen Dual-omics-18 PerturbFate pooled scre…
- GSM8829753 PerturbFate pooled screen Dual-omics-19 PerturbFate pooled scre…
- GSM8829754 PerturbFate pooled screen Dual-omics-20 PerturbFate pooled scre…
- GSM8829755 PerturbFate pooled screen Dual-omics-21 PerturbFate pooled scre…
- GSM8829756 PerturbFate pooled screen Dual-omics-22 PerturbFate pooled scre…
- GSM8829757 PerturbFate pooled screen Dual-omics-23 PerturbFate pooled scre…
- GSM8829758 PerturbFate pooled screen Dual-omics-24 PerturbFate pooled scre…
- GSM8829759 PerturbFate pooled screen Dual-omics-25 PerturbFate pooled scre…
- GSM8829760 PerturbFate pooled screen Dual-omics-26 PerturbFate pooled scre…
- GSM8829761 PerturbFate pooled screen Dual-omics-27 PerturbFate pooled scre…
- GSM8829762 PerturbFate pooled screen Dual-omics-28 PerturbFate pooled scre…
- GSM8829763 PerturbFate pooled screen Dual-omics-29 PerturbFate pooled scre…
- GSM8829764 PerturbFate pooled screen Dual-omics-30 PerturbFate pooled scre…
- GSM8829765 PerturbFate pooled screen Dual-omics-31 PerturbFate pooled scre…
- GSM8829766 PerturbFate pooled screen Dual-omics-32 PerturbFate pooled scre…
- GSM8829767 PerturbFate pooled screen Dual-omics-33 PerturbFate pooled scre…
- GSM8829768 PerturbFate pooled screen Dual-omics-34 PerturbFate pooled scre…
- GSM8829769 PerturbFate pooled screen Dual-omics-35 PerturbFate pooled scre…
- GSM8829770 PerturbFate pooled screen Dual-omics-36 PerturbFate pooled scre…
- GSM8829771 PerturbFate pooled screen Dual-omics-37 PerturbFate pooled scre…
- GSM8829772 PerturbFate pooled screen Dual-omics-38 PerturbFate pooled scre…
- GSM8829773 PerturbFate pooled screen Dual-omics-39 PerturbFate pooled scre…
- GSM8829774 PerturbFate pooled screen Dual-omics-40 PerturbFate pooled scre…
+ 280 more — browse all 320 samples with per-sample file links →
- GSE12391 Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi 114 samples same disease briefing · shares melanoma
- GSE134459 Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 73 samples same disease briefing · shares melanoma
- GSE230489 RNA-sequencing of cutaneous melanoma and non-small cell lung cancer biopsies 38 samples same disease briefing · shares melanoma
- GSE100797 Mutational and neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma 25 samples same disease briefing · shares melanoma
- GSE123728 Clinical and Immunologic Activity of a Single Dose of Neoadjuvant PD-1 Blockade and Predictors of Clinical Outcomes in Resectable Melanoma 24 samples same disease briefing · shares melanoma
- GSE130956 Investigation of ST8SIA1 expression in icaritin-treated and untreated melanoma cell lines 12 samples same disease briefing · shares melanoma
- GSE140150 A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 6 samples same disease briefing · shares melanoma
- GSE142751 Genome-wide maps of chromatin state in 142 cancer cell lines [cell line] 855 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.